173 related articles for article (PubMed ID: 31926818)
1. Determinants of Variation in the Use of Adjuvant Chemotherapy for Stage III Colon Cancer in England.
Boyle JM; Kuryba A; Cowling TE; Aggarwal A; Hill J; van der Meulen J; Walker K; Braun MS
Clin Oncol (R Coll Radiol); 2020 May; 32(5):e135-e144. PubMed ID: 31926818
[TBL] [Abstract][Full Text] [Related]
2. Large age and hospital-dependent variation in administration of adjuvant chemotherapy for stage III colon cancer in southern Netherlands.
van Steenbergen LN; Rutten HJT; Creemers GJ; Pruijt JFM; Coebergh JWW; Lemmens VEPP
Ann Oncol; 2010 Jun; 21(6):1273-1278. PubMed ID: 19880434
[TBL] [Abstract][Full Text] [Related]
3. Use and Effectiveness of Adjuvant Chemotherapy for Stage III Colon Cancer: A Population-Based Study.
Booth CM; Nanji S; Wei X; Peng Y; Biagi JJ; Hanna TP; Krzyzanowska MK; Mackillop WJ
J Natl Compr Canc Netw; 2016 Jan; 14(1):47-56. PubMed ID: 26733554
[TBL] [Abstract][Full Text] [Related]
4. Impact of age on the use of adjuvant treatments in patients undergoing surgery for colorectal cancer: patients with stage III colon or stage II/III rectal cancer.
Sarasqueta C; Perales A; Escobar A; Baré M; Redondo M; Fernández de Larrea N; Briones E; Piera JM; Zunzunegui MV; Quintana JM;
BMC Cancer; 2019 Jul; 19(1):735. PubMed ID: 31345187
[TBL] [Abstract][Full Text] [Related]
5. Age and adjuvant chemotherapy use after surgery for stage III colon cancer.
Schrag D; Cramer LD; Bach PB; Begg CB
J Natl Cancer Inst; 2001 Jun; 93(11):850-7. PubMed ID: 11390534
[TBL] [Abstract][Full Text] [Related]
6. Estimating the optimal rate of adjuvant chemotherapy utilization for stage III colon cancer.
Karim S; Booth CM; Brennan K; Peng Y; Siemens DR; Krzyzanowska MK; Mackillop WJ
Cancer Med; 2019 Sep; 8(12):5590-5599. PubMed ID: 31407518
[TBL] [Abstract][Full Text] [Related]
7. The effect of comorbidity on the use of adjuvant chemotherapy and type of regimen for curatively resected stage III colon cancer patients.
Hsieh MC; Thompson T; Wu XC; Styles T; O'Flarity MB; Morris CR; Chen VW
Cancer Med; 2016 May; 5(5):871-80. PubMed ID: 26773804
[TBL] [Abstract][Full Text] [Related]
8. Administration of adjuvant chemotherapy for stage II-III colon cancer patients: An European population-based study.
Babaei M; Balavarca Y; Jansen L; Lemmens V; van Erning FN; van Eycken L; Vaes E; Sjövall A; Glimelius B; Ulrich CM; Schrotz-King P; Brenner H
Int J Cancer; 2018 Apr; 142(7):1480-1489. PubMed ID: 29159866
[TBL] [Abstract][Full Text] [Related]
9. Management of stage III colon cancer in the elderly: Practice patterns and outcomes in the general population.
Merchant SJ; Nanji S; Brennan K; Karim S; Patel SV; Biagi JJ; Booth CM
Cancer; 2017 Aug; 123(15):2840-2849. PubMed ID: 28346663
[TBL] [Abstract][Full Text] [Related]
10. Underutilization or appropriate care? Assessing adjuvant chemotherapy use and survival in 3 heterogenous subpopulations with stage II/III colorectal cancer within a large integrated health system.
Chen Y; Shankaran V; Hahn EE; Haupt EC; Bansal A
J Manag Care Spec Pharm; 2023 Jun; 29(6):635-646. PubMed ID: 37276035
[No Abstract] [Full Text] [Related]
11. Hospital Variability in Use of Adjuvant Chemotherapy for Patients with Stage 2 and 3 Colon Cancer.
Daly MC; Hanseman DJ; Abbott DE; Shah SA; Paquette IM
Dis Colon Rectum; 2016 Dec; 59(12):1134-1141. PubMed ID: 27824698
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant chemotherapy for stage III colon cancer: implications of race/ethnicity, age, and differentiation.
Jessup JM; Stewart A; Greene FL; Minsky BD
JAMA; 2005 Dec; 294(21):2703-11. PubMed ID: 16333005
[TBL] [Abstract][Full Text] [Related]
13. Decreasing Use of Chemotherapy in Older Patients With Stage III Colon Cancer Irrespective of Comorbidities.
Walter V; Boakye D; Weberpals J; Jansen L; Haefeli WE; Martens UM; Knebel P; Chang-Claude J; Hoffmeister M; Brenner H
J Natl Compr Canc Netw; 2019 Sep; 17(9):1089-1099. PubMed ID: 31487678
[TBL] [Abstract][Full Text] [Related]
14. Opportunity lost: Adjuvant chemotherapy in patients with stage III colon cancer remains underused.
Becerra AZ; Probst CP; Tejani MA; Aquina CT; González MG; Hensley BJ; Noyes K; Monson JR; Fleming FJ
Surgery; 2015 Sep; 158(3):692-9. PubMed ID: 26032822
[TBL] [Abstract][Full Text] [Related]
15. Complicated postoperative recovery increases omission, delay and discontinuation of adjuvant chemotherapy in patients with Stage III colon cancer.
van der Geest LG; Portielje JE; Wouters MW; Weijl NI; Tanis BC; Tollenaar RA; Struikmans H; Nortier JW;
Colorectal Dis; 2013; 15(10):e582-91. PubMed ID: 23679338
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant Chemotherapy for Stage II Colon Cancer: Practice Patterns and Effectiveness in the General Population.
Booth CM; Nanji S; Wei X; Peng Y; Biagi JJ; Hanna TP; Krzyzanowska MK; Mackillop WJ
Clin Oncol (R Coll Radiol); 2017 Jan; 29(1):e29-e38. PubMed ID: 27663601
[TBL] [Abstract][Full Text] [Related]
17. Safety and Efficacy of Oxaliplatin Doublet Adjuvant Chemotherapy in Elderly Patients With Stage III Colon Cancer.
Brungs D; Aghmesheh M; de Souza P; Carolan M; Clingan P; Rose J; Ranson M
Clin Colorectal Cancer; 2018 Sep; 17(3):e549-e555. PubMed ID: 29861156
[TBL] [Abstract][Full Text] [Related]
18. Benefit of Postresection Adjuvant Chemotherapy for Stage III Colon Cancer in Octogenarians: Analysis of the National Cancer Database.
Bergquist JR; Thiels CA; Spindler BA; Shubert CR; Hayman AV; Kelley SR; Larson DW; Habermann EB; Pemberton JH; Mathis KL
Dis Colon Rectum; 2016 Dec; 59(12):1142-1149. PubMed ID: 27824699
[TBL] [Abstract][Full Text] [Related]
19. Impact of race/ethnicity and socioeconomic status on adjuvant chemotherapy use among elderly patients with stage III colon cancer.
Hsieh MC; Chiu YW; Velasco C; Wu XC; O'Flarity MB; Chen VW
J Registry Manag; 2013; 40(4):180-7. PubMed ID: 24625772
[TBL] [Abstract][Full Text] [Related]
20. Effect of adjuvant chemotherapy on survival benefit in stage III colon cancer patients stratified by age: a Japanese real-world cohort study.
Kawamura H; Morishima T; Sato A; Honda M; Miyashiro I
BMC Cancer; 2020 Jan; 20(1):19. PubMed ID: 31906959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]